mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.02 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
AC55649 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.03 |